312-494-9800
citycap@city-cap.com
Chicago, Illinois – January 13, 2026; City Capital Advisors, a Chicago-based middle market investment bank, is pleased to announce that it acted as the exclusive financial advisor to Proveris Scientific Corporation (“Proveris”) in the sale of the company to an independent managed investment subsidiary of Investindustrial Growth III SCSp (“Investindustrial”).
Through its investment in and in partnership with Proveris’ management, Investindustrial aims to drive further Proveris’ expansion and build a leading pharmaceutical testing equipment group positioned for continued global growth, both through organic and acquisitive expansion in its existing markets and in adjacent pharmaceutical testing equipment categories. With a global reputation for innovation and quality and a broad international sales base, Proveris is exceptionally well positioned to serve as the ideal foundation for this ambitious growth strategy.
Building on the proven success of its affiliates in providing advisory support to companies across the equipment, automation and healthcare industries, with investments such as Arterex, Ourvita, GeneraLife, Lifebrain, and Omnia Technologies, Investindustrial brings the deep sector experience, integration capabilities, operational expertise and global presence needed to support Proveris’ continued development while preserving its science-led culture and customer focus.
Founder Dino Farina, a pioneer in the OINDP testing equipment industry, will remain with Proveris and has reinvested as a minority shareholder alongside Investindustrial, reinforcing Investindustrial’s reputation as the partner of choice for ambitious founders, entrepreneurs and family business owners.
Dino Farino, Founder & CEO of Proveris, said: “Investindustrial represents everything I could hope for in a partner focused on strategic growth, investment and value creation for Proveris’ customers and the Proveris team. I am very excited for the future working with the Investindustrial team.”
Andrea C. Bonomi, Chairman of the Investindustrial Industrial Advisory Board, said: “Proveris represents an exceptional platform to build a global leader in specialty pharmaceutical testing equipment. We greatly admire what Dino and the team have achieved and look forward to partnering on the next phase of growth. By leveraging our industrial expertise, international reach, and strong integration capabilities, we aim to accelerate growth and expand the company’s global footprint”.
Stewart B. Davis M.D., Managing Director at City Capital Advisors, said: “Dino and the entire Proveris team spent years building an incredible business and they are undoubtedly the top name in OINDP analytics. This made them an ideal candidate to become a platform for private equity growth. Our team at CCA could not be happier with the partner we found for them, as well as an ideal structure for future growth”.
About Proveris Scientific Corporation
Proveris is a leader in the design and manufacture of spray and aerosol testing instrumentation, software and laboratory solutions for the pharmaceutical industry with a specialization on orally inhaled and nasal drug products (“OINDP”).
Founded by Dino J. Farina, and headquartered in Hudson, Massachusetts, Proveris has been serving the world’s leading pharmaceutical companies since 1995 and is the global provider of choice for spray characterization testing instrumentation, lab services and OINDP expertise. Proveris’ technologies are deeply embedded in customer workflows and regulatory processes, supporting reproducibility, data continuity, and long-term customer relationships. In serving a diverse and global customer base of branded and generic pharmaceutical companies, contract development organizations, device makers and regulatory agencies, Proveris’ technologies and expertise are integral to organizations for OINDP approvals in more than 30 countries.
About InvestIndustrial
Investindustrial is a leading European group of independently managed investment, holding and advisory companies with €17 billion of raised fund capital. With ESG principles deeply embedded into the Firm’s core approach, Investindustrial has a 35-year history of providing midmarket companies with capital, industrial expertise, operational focus and global platforms to accelerate sustainable value creation and international expansion.
About City Capital Advisors
City Capital Advisors, a FINRA registered broker-dealer, is a results-oriented investment banking advisory firm and has one of the top teams in the country for small to medium sized Medtech and Med Device M&A, capitalizing on extensive industry medtech expertise. Each of City Capital’s Managing Directors has more than 20 years of investment banking experience, offering clients the judgment and transaction management expertise honed from successfully executing more than $60 billion of collective merger and capital market transactions. Client engagements are managed exclusively by experienced senior investment bankers, allowing business owners to capture maximum value for their companies and to exceed shareholder objectives.